MCW Pharmacology and Toxicology

Please wait while we gather your results.

Medical College of Wisconsin names Dr. Carol Williams as Eminent Scholar

Apr. 27 - Carol L. Williams, PhD, was awarded Eminent Scholar designation at the March meeting of the Board of Trustees of the Medical College of Wisconsin (MCW). She joins Mingyu Liang, MB, PhD, who was named an Eminent Scholar in September 2015, and William Drobyski, MD, and Brian Link, PhD, who were named Eminent Scholars in March 2015.

MCW receives $2.8 million in grants to investigate kidney disease

Apr. 6 - The Medical College of Wisconsin (MCW) has received two grants totaling $2.8 million to investigate treatments for diseases of the kidney. The first grant is a 5-year, $2.3 million grant from the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases to investigate the development of a drug to treat Type 2 diabetes and metabolic syndrome.

Dr. Coryce Haavik, former research and grad school leader, died Feb. 18 at age 82

Feb. 23 - Coryce Haavik, PhD, former pharmacology and toxicology faculty member who held important leadership positions in MCW’s research and graduate education missions, died Feb. 18 while teaching overseas. She was 82 years old.

Graduate student aims at brain research

Using technology and tools that the Medical College of Wisconsin was a world leader in developing, a PhD student in the Graduate School of Biomedical Sciences and her faculty mentor are pursuing brain research with potential to benefit cancer patients.

Dr. Hillard Named Associate Dean for Research

Dec. 4 - Cecilia J. Hillard, PhD, professor of pharmacology and toxicology and director of the Neuroscience Research Center, has been named associate dean for research at the Medical College of Wisconsin (MCW).Lake Country Now

Dr. Kathryn Gauthier, faculty member in pharmacology and toxicology, dies at age 60

July 16 - Kathryn M. “Kathy” Gauthier, PhD, associate professor of pharmacology and toxicology, died Monday, July 13. She was 60 years old.

Dr. Imig Comments on Identification of Key Mechanism in Neuropathic Pain

July 14 - John Imig, PhD provides expert comment on the identification of a key mechanism in neuropathic pain by scientists at the University of California, Davis. The discovery could eventually benefit millions of patients with chronic pain from trauma, diabetes, shingles, multiple sclerosis or other conditions that cause nerve damage. UC-Davis

Dr. Imig Expects Companies to Invest in Drugs Targeted to Gene Mutations

July 13 - John Imig, PhD, (Pharmacology & Toxicology) tells International Business Times that he expects the debut of the PCSK-9 inhibitors (which targets a mutation in the PCSK-9 gene, which causes high cholesterol) will spur companies to invest in this area as scientists continue their search for genetic factors underlying major diseases. International Business Times

Dr. Williams Receives $1.75 NCI Grant to Repurpose Medications to Fight Breast Cancer

May 6 - Carol Williams, PhD, (Pharmacology & Toxicology) received a five-year, $1.75 million grant from the National Cancer Institute to study a new approach at limiting the spread of breast cancer. Dr. Williams will repurpose existing medications that target a family of molecules suspected in the spread of breast cancer. The medications are not currently used to treat cancers. Health Canal

Media Contacts

Maureen Remmel
External Communications Consultant
(414) 955-4744 (Office)
media@mcw.edu

Richard N. Katschke
Associate Vice President
(414) 955-4748
rkatschk@mcw.edu

Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53226
(414) 955-8296
Directions & Maps
© 2016

Page Updated 12/08/2015
Top